• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Applovin, Boeing Rise Among Monday’s Morning Market Cap Stock Movers

by October 21, 2024
written by October 21, 2024

Monday’s stock market has experienced a variety of intra-day movements, with significant activity in both the mega-cap and large-cap categories. Stocks such as NVIDIA (NASDAQ:NVDA), Applovin (APP) and Boeing Co (NYSE:BA) have seen notable increases, while Cigna Corp (NYSE:CI) and Diamond Eagle Acquisition Corp (DKNG) have faced declines. Here’s an overview of some of the most impactful stock movers, spanning from mega-caps to small caps.

Mega-Cap Movers:

NVIDIA (NVDA): +1.9%; sees continued momentum on AI gains

Large-Cap Stock Movers:

Applovin (APP); BofA raises price target to $210; +8.24%
Boeing Co (BA); Emirates SkyCargo to Expand Fleet, Capacity with Five More Boeing 777 Freighters; +4.14%
Kenvue Inc (NYSE:KVUE); Starboard Value Builds Stake In Tylenol-Maker Kenvue – WSJ; +6.56%
Ritchie Bros. Auctioneers (NYSE:RBA); +6.18%
Marvell (NASDAQ:MRVL) Technology Group Ltd (MRVL); +3.41%
Cigna Corp (CI); falls on report it is in talks again to merge with Huana (HUM); -4.16%
DraftKings (NASDAQ:DKNG); -4.11%
Monolithic Power (NASDAQ:MPWR); -3.52%

Mid-Cap Stock Movers:

Oklo (OKLO); sees continued momentum on big tech’s nuclear ambitions; +9.24%
Construction Partners Inc (NASDAQ:ROAD); CPI announces acquisition of Lone Star Paving for $654 million; +12.22%
Ikonics Corp (WULF); +10.4%
Alkami Technology (ALKT); +5.94%
Ibotta (IBTA); +5.94%
Neumora Therapeutics (NMRA); -14.55%
VF Corp (NYSE:VFC); JP Morgan adds to negative catalyst watch; -6.76%
Avidity Biosciences Inc (RNA); -7.64%

Small-Cap Stock Movers:

Nano Nuclear Energy (NNE); sees continued momentum on big tech’s nuclear ambitions; +16.09%
Viad Corp (NYSE:VVI); Viad to sell GES unit for $535 million, to become Pursuit; +15.29%
Ehang Holdings Ltd (NASDAQ:EH); +14.3%
Audioeye, Inc (AEYE); +12.05%
European Biotech Acquisition (OCS); Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees; +10.66%
HPX (AMBI); +7.74%
Alpha Teknova (TKNO); -7.0%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Wall Street analysts initiate coverage of BioAge Labs
next post
Spirit AeroSystems to furlough 700 workers as Boeing machinist strike continues

You may also like

BASF results down on impairments, restructuring

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • China outlines more controls on exports of rare earths and technology

      October 10, 2025
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

      October 7, 2025
    • YouTube to pay $24 million to settle Trump lawsuit

      October 1, 2025
    • Charlie Javice sentenced to 7 years in prison for fraudulent $175M sale of aid startup

      October 1, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (651)
    • Stock (6,426)

    Latest News

    • China outlines more controls on exports of rare earths and technology
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

    Popular News

    • How exceptional is US exceptionalism?
    • Australia urges greater internet user choice amid Google dominance, genAI

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy